Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001513162-23-000010
Filing Date
2023-01-30
Accepted
2023-01-30 11:36:42
Documents
1
Period of Report
2023-01-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3114
  Complete submission text file 0001513162-23-000010.txt   4726
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9496452111
BIOMERICA INC (Issuer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 966 OCHO RIOS DR DANVILLE CA 94526
Business Address
Coste Catherine (Reporting) CIK: 0001821432 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37863 | Film No.: 23566127